drugset / Trial / NCT00087139

Ixabepilone in Treating Patients With Metastatic Prostate Cancer

NCT00087139

Phase 2 Completed 124 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

Drugs used in chemotherapy, such as ixabepilone, work in different ways to stop tumor cells from dividing so they stop growing or die. This phase II trial is studying how well ixabepilone works in treating patients with metastatic prostate cancer that has not responded to previous hormone therapy.

Timeline

Start
2004-09
Primary completion
2009-04
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Ixabepilone Small molecule Intravenous